Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

phenotyping

- PMLiVE

England’s Cancer Drugs Fund: Naughty or NICE?

The decision to extend the CDF raises questions on the future of cancer drug access on the NHS

- PMLiVE

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

- PMLiVE

Omega buys pharmacy to understand customers

Will turn Warman-Freed in North London into ‘learning pharmacy’

UK Life Sciences Strategy - one year on

UK invests in genetic research for cancer and rare diseases

Government outlines £300m boost for 100,000 Genomes Project

UK minister: ‘End animal testing’

LibDem MP Norman Baker says there is an economic case for finding an alternative

UK flag

Pharma firms open up drug libraries to UK researchers

AZ, GSK, Janssen, Lilly, Pfizer, Takeda and UCB partner with Medical Research Council

UK flag

Antimicrobial resistance priority for new UK science minister

Greg Clark announces collaboration led by Medical Research Council

- PMLiVE

UK appoints Greg Clark as new science minister

Cabinet reshuffle also sees George Freeman made minister for life sciences

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

UK flag

Pharma industry backs UK antibiotics plan

GSK and ABPI back David Cameron’s call for global action on antimicrobial resistance

- PMLiVE

UK’s MRC launches public-private push on dementia research

AstraZeneca, GSK and J&J will support £16m programme

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links